Mathematical Prognostic Biomarker Models for Treatment Response and survival in Epithelial Ovarian Cancer

Mathematical Prognostic Biomarker Models for Treatment Response and survival in Epithelial Ovarian Cancer

Following initial standard chemotherapy (platinum/taxol), more than 75% of those patients with advanced stage epithelial ovarian cancer (EOC) experience a recurrence. There are currently no accurate prognostic tests that, at the time of the diagnosis/surgery, can identify those patients with advance...

Full description

Bibliographic Details
Main Authors: Jason B. Nikas, Kristin L.M. Boylan, Amy P.N. Skubitz, Walter C. Low
Format: Article
Language:English
Published: SAGE Publishing 2011-01-01
Series:Cancer Informatics
Online Access:https://doi.org/10.4137/CIN.S8104

Similar Items

Similar Items